|
DDX19B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.275600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.493160E-01 |
| Normal-vs-Stage2 |
5.163000E-01 |
| Normal-vs-Stage3 |
9.281700E-03 |
| Normal-vs-Stage4 |
4.270200E-02 |
| Stage1-vs-Stage2 |
7.434400E-01 |
| Stage1-vs-Stage3 |
1.003440E-01 |
| Stage1-vs-Stage4 |
2.896800E-01 |
| Stage2-vs-Stage3 |
1.597760E-01 |
| Stage2-vs-Stage4 |
2.654000E-01 |
| Stage3-vs-Stage4 |
8.543400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.371600E-02 |
| Normal-vs-AfricanAmerican |
5.488200E-01 |
| Normal-vs-Asian |
8.896600E-01 |
| Caucasian-vs-AfricanAmerican |
5.688000E-01 |
| Caucasian-vs-Asian |
1.355370E-01 |
| AfricanAmerican-vs-Asian |
6.247400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.056800E-01 |
| Normal-vs-Female |
3.322500E-02 |
| Male-vs-Female |
4.871000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.952600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.330000E-02 |
| Normal-vs-Age(61-80Yrs) |
8.300100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.936410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.997170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.577900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.903800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.725200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.894200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.505400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.300400E-01 |
| Classical-VS-Follicular |
2.086800E-01 |
| Classical-VS-Other |
6.579800E-01 |
| Classical-VS-Normal |
2.037800E-01 |
| Tall-VS-Follicular |
8.342400E-01 |
| Tall-VS-Other |
8.623000E-01 |
| Tall-VS-Normal |
3.974000E-02 |
| Follicular-VS-Other |
9.651800E-01 |
| Follicular-VS-Normal |
4.886200E-02 |
| Other-VS-Normal |
2.977600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.331700E-02 |
| Normal-vs-N1 |
5.676400E-02 |
| N0-vs-N1 |
6.037200E-01 |
|
|
